1. Home
  2. NTHI vs RILY Comparison

NTHI vs RILY Comparison

Compare NTHI & RILY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTHI
  • RILY
  • Stock Information
  • Founded
  • NTHI 2008
  • RILY 1973
  • Country
  • NTHI United States
  • RILY United States
  • Employees
  • NTHI N/A
  • RILY N/A
  • Industry
  • NTHI Biotechnology: Pharmaceutical Preparations
  • RILY Investment Managers
  • Sector
  • NTHI Health Care
  • RILY Finance
  • Exchange
  • NTHI Nasdaq
  • RILY Nasdaq
  • Market Cap
  • NTHI 110.9M
  • RILY 91.8M
  • IPO Year
  • NTHI N/A
  • RILY 2007
  • Fundamental
  • Price
  • NTHI $5.10
  • RILY $5.58
  • Analyst Decision
  • NTHI
  • RILY
  • Analyst Count
  • NTHI 0
  • RILY 0
  • Target Price
  • NTHI N/A
  • RILY N/A
  • AVG Volume (30 Days)
  • NTHI 284.4K
  • RILY 1.8M
  • Earning Date
  • NTHI 01-01-0001
  • RILY 08-14-2025
  • Dividend Yield
  • NTHI N/A
  • RILY N/A
  • EPS Growth
  • NTHI N/A
  • RILY N/A
  • EPS
  • NTHI N/A
  • RILY N/A
  • Revenue
  • NTHI $79,990.00
  • RILY $854,383,000.00
  • Revenue This Year
  • NTHI N/A
  • RILY N/A
  • Revenue Next Year
  • NTHI N/A
  • RILY N/A
  • P/E Ratio
  • NTHI N/A
  • RILY N/A
  • Revenue Growth
  • NTHI 13.52
  • RILY N/A
  • 52 Week Low
  • NTHI $3.20
  • RILY $2.67
  • 52 Week High
  • NTHI $25.00
  • RILY $20.36
  • Technical
  • Relative Strength Index (RSI)
  • NTHI N/A
  • RILY 65.70
  • Support Level
  • NTHI N/A
  • RILY $5.27
  • Resistance Level
  • NTHI N/A
  • RILY $6.33
  • Average True Range (ATR)
  • NTHI 0.00
  • RILY 0.70
  • MACD
  • NTHI 0.00
  • RILY 0.12
  • Stochastic Oscillator
  • NTHI 0.00
  • RILY 74.35

About NTHI NeOnc Technologies Holdings Inc. Common Stock

NeOnc Technologies Holdings Inc. is the developer of a novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company product includes NEO100, which commenced Phase 2a clinical trials, which is used for treating glioblastoma, and has Orphan Drug and Fast Track designation from the United States Food and Drug Administration ("FDA").

About RILY B. Riley Financial Inc.

B. Riley Financial Inc is a diversified financial services company. The company through its subsidiaries offers investment banking and financial services to corporate, institutional, and high-net-worth clients and also asset disposition, valuation and appraisal, and capital advisory services to retail, wholesale, institutional, lenders, capital providers, private equity investors, and professional services firms in United States, Canada, and Europe. It also provides internet access and subscription services. The reportable operating segments of the company include Capital Markets, Wealth Management, Financial Consulting, Auction and Liquidation, Communications segment, and Consumer products segment.

Share on Social Networks: